Delivery Order SPE2DB25D3008-SPE2DB25FRCDS

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,845.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of WEGOVY 2.4 mg/0.75 ml pen 0.75 ml. The contract has an ultimate completion date of April 4, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a $11,667.59 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for the supply of WEGOVY 2.4 mg/0.75 ml pen 0.75ml, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support...
This is a $1,682.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication, with a performance period through June 18, 2025. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
This is a $9,628.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a performance period through June 27, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026....
This is a $9,041.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The order has a completion date of June 24, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to...
This is a $10,190.13 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a medication. The contract has a completion date of May 21, 2025 and is not a set-aside contract. AmerisourceBergen Drug Corp holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a $6,841.34 firm fixed price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a performance period through June 10, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. This IDC, designated as SPE2DX,...
This is a $1,638.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $11,691.56 and a period of performance ending on April 9, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $4,418.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a period of performance through November 3, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB25D3008
    Indefinite Delivery Contract
  • SPE2DB25D3008-SPE2DB25FRCDS
    Delivery Order

This is a $11,888.26 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The delivery order has an ultimate completion date of May 28, 2025.

Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a global pharmaceutical support vehicle with a performance period through December 2026. This IDC allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 8/31/25, 1:03 AM